| Website | groovebiopharma.com |
| Category | BioTech |
| Phone | 206-957-7300 |
| info@groovebiopha... | |
| Employees |
| TOTAL | $6M |
| FUNDING TOTAL | $6M |
| Series B, 12/11 ARCH Venture Partners OVP Venture Partners Versant Ventures WRF Capital | $6M |
Groove Biopharma focuses on the generation of novel microRNA (miRNA) therapeutics with improved properties, including higher potency and enhanced pharmacodynamic activity. Endogenous microRNAs (miRNAs) are involved in extensive regulatory networks for many target genes and pathways. Groove Biopharma’s core technology addresses a new avenue of nucleotide therapeutic drug discovery via modulation of cellular miRNA. Using exclusive technology, Groove Biopharma is generating a series of lead candidates with the potential to be best-in-class therapeutics. By incorporating proprietary structural modifications into miRNA therapeutics, the Groove Biopharma technology platform presents promising potential for treating a wide range of diseases, including cancer, fibrosis, and infectious disease.
